Tieton Capital Management LLC decreased its position in shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Free Report) by 5.8% in the second quarter, HoldingsChannel reports. The firm owned 39,702 shares of the company’s stock after selling 2,425 shares during the quarter. Tieton Capital Management LLC’s holdings in Nature’s Sunshine Products were worth $598,000 at the end of the most recent reporting period.
Several other large investors have also recently made changes to their positions in NATR. Jump Financial LLC bought a new position in shares of Nature’s Sunshine Products during the 4th quarter valued at approximately $208,000. Hillsdale Investment Management Inc. grew its stake in shares of Nature’s Sunshine Products by 50.3% in the 4th quarter. Hillsdale Investment Management Inc. now owns 198,730 shares of the company’s stock worth $3,436,000 after buying an additional 66,500 shares in the last quarter. Trexquant Investment LP bought a new stake in shares of Nature’s Sunshine Products in the 4th quarter worth about $217,000. Wasatch Advisors LP bought a new position in shares of Nature’s Sunshine Products in the 4th quarter valued at about $7,430,000. Finally, BNP Paribas Financial Markets grew its position in Nature’s Sunshine Products by 12.7% in the first quarter. BNP Paribas Financial Markets now owns 15,207 shares of the company’s stock worth $316,000 after acquiring an additional 1,715 shares in the last quarter. 79.40% of the stock is owned by institutional investors.
Nature’s Sunshine Products Stock Down 1.8 %
NATR stock opened at $13.81 on Tuesday. The firm has a market cap of $258.66 million, a price-to-earnings ratio of 16.25 and a beta of 0.87. Nature’s Sunshine Products, Inc. has a twelve month low of $10.81 and a twelve month high of $21.72. The business’s fifty day simple moving average is $14.41 and its two-hundred day simple moving average is $16.32.
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on NATR shares. Canaccord Genuity Group started coverage on Nature’s Sunshine Products in a research note on Friday. They issued a “buy” rating and a $18.00 price objective for the company. Canaccord Genuity Group initiated coverage on shares of Nature’s Sunshine Products in a research report on Friday. They set a “buy” rating and a $18.00 price objective on the stock. StockNews.com upgraded shares of Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a report on Tuesday, September 10th. Finally, DA Davidson cut their price target on shares of Nature’s Sunshine Products from $23.00 to $21.00 and set a “buy” rating on the stock in a report on Monday, August 12th.
Read Our Latest Research Report on Nature’s Sunshine Products
About Nature’s Sunshine Products
Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Further Reading
- Five stocks we like better than Nature’s Sunshine Products
- What is the FTSE 100 index?
- Don’t Miss Out: NETGEAR’s Turnaround Signals Big Potential
- Best Aerospace Stocks Investing
- Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
- Compound Interest and Why It Matters When Investing
- Silver’s Breakout: 3 Momentum Stocks You Can’t Miss
Want to see what other hedge funds are holding NATR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Free Report).
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.